American Century Companies’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-67,071
| Closed | -$1.77M | – | 2374 |
|
|
2021
Q4 | $1.77M | Buy |
67,071
+2,213
| +3% | +$58.4K | ﹤0.01% | 1412 |
|
|
2021
Q3 | $6.53M | Buy |
64,858
+20
| +0% | +$2.01K | ﹤0.01% | 958 |
|
|
2021
Q2 | $9.18M | Buy |
64,838
+31,185
| +93% | +$4.41M | 0.01% | 841 |
|
|
2021
Q1 | $3.36M | Sell |
33,653
-712
| -2% | -$71K | ﹤0.01% | 1038 |
|
|
2020
Q4 | $4.25M | Buy |
34,365
+49
| +0.1% | +$6.06K | ﹤0.01% | 911 |
|
|
2020
Q3 | $3.34M | Buy |
34,316
+231
| +0.7% | +$22.5K | ﹤0.01% | 859 |
|
|
2020
Q2 | $5.32M | Buy |
34,085
+8,558
| +34% | +$1.34M | 0.01% | 767 |
|
|
2020
Q1 | $3.69M | Sell |
25,527
-5,564
| -18% | -$803K | ﹤0.01% | 770 |
|
|
2019
Q4 | $6.36M | Buy |
31,091
+1,688
| +6% | +$345K | 0.01% | 772 |
|
|
2019
Q3 | $2.36M | Sell |
29,403
-2,506
| -8% | -$201K | ﹤0.01% | 946 |
|
|
2019
Q2 | $3.01M | Sell |
31,909
-87
| -0.3% | -$8.21K | ﹤0.01% | 949 |
|
|
2019
Q1 | $2.74M | Sell |
31,996
-9,128
| -22% | -$780K | ﹤0.01% | 946 |
|
|
2018
Q4 | $2.31M | Buy |
41,124
+11,000
| +37% | +$617K | ﹤0.01% | 945 |
|
|
2018
Q3 | $2.46M | Buy |
+30,124
| New | +$2.46M | ﹤0.01% | 999 |
|